YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations

Aug.10.2022
YOOZ Launches Comprehensive Laboratory to Meet New E-Cigarette Regulations
YOOZ builds a comprehensive lab to promote research and innovation for electronic cigarettes, prioritizing quality and safety.

Starting from May 1, 2022, the mandatory national standard for electronic cigarettes was approved by the State Administration for Market Regulation and the National Standardization Management Committee. The "Regulations on the Management of Electronic Cigarettes" issued by the State Tobacco Monopoly Administration will also come into effect. The orderly implementation of the national standard and regulations not only marks the formal entry of the electronic cigarette industry into a phase with legal compliance, but also serves as a driving force for guiding electronic cigarette companies to gradually develop in the direction of scientific research and innovation. In order to better implement regulatory requirements and promote comprehensive innovation in the industry through scientific and technological innovation, YOOZ, a leading electronic cigarette company, has recently publicly launched a comprehensive laboratory built around CNAS standards.


In response, YOOZ, a department related to the company, stated that the implementation of both the national standard for electronic cigarettes and the new regulations is a boost for the long-term development of the industry. YOOZ has consistently relied on scientific research to support a more sustainable industry development strategy. This is both a responsibility and a necessary attitude for electronic cigarette companies to maintain a stable development trajectory.


With meticulous analysis, we always adhere to the principle of "customer first.


As we all know, consumers' greatest concerns always revolve around product quality and safety. Electronic cigarettes, which are often thought to have a low technological threshold, are at risk of having their quality and safety overlooked. However, the lower the technological threshold of a product, the greater the need for safety production and compliance. Prior to regulations being enforced, the electronic cigarette market was filled with various generic and fake products. Guarding consumer safety has become one of the crucial issues in the development of the industry. As a leading enterprise in the industry, YOOZ has always upheld the principle of "putting users first" and continuously strives to protect consumer rights.


Although e-cigarettes are often mocked as low-tech products, every production process and component must go through a rigorous and safe production process to prevent products with quality defects from entering the market. YOOZ's laboratory took half a year to prepare and put into use, and was built in accordance with CNAS standards. The testing center mainly consists of a physical laboratory, a chemical laboratory, an electrical laboratory, and an environmental laboratory, with more than 70 instruments and the ability to conduct over 100 standardized tests. YOOZ has a standardized testing method and strict quality management system in place for quality control and testing, thoroughly evaluating product performance, reliability, and safety throughout the product development process.


YOOZ Citrus Detection Center has developed simulated artificial smoking detection devices that mimic users' daily habits to provide more accurate experiences. Additionally, these devices help the company develop products that meet the needs of different users and provide more options. In addition, the batteries used in YOOZ products undergo over 400 cycles of charge and discharge in a longevity laboratory, as well as safety performance testing under various extreme conditions. This ensures that the product has good performance when frequently used by users.


It is noteworthy that the YOOZ Lemon Lab has taken the initiative to add a waterproof test in accordance with the National Standard for Electronic Cigarettes and the Measures for the Administration of Electronic Cigarettes. This demonstrates YOOZ Lemon's determination and implementation speed in compliance development, as well as their effort to improve and meet national standard requirements.


Moving towards research-oriented businesses is the development goal and mission of electronic cigarette companies.


YOOZ Laboratory not only bears the responsibility of safety and innovation, but also serves as a central hub that connects and streamlines the upstream and downstream industries. For businesses, the laboratory takes control of both research and production standards, leading to a more selective and high-quality choice of suppliers through strict requirements. This stimulates the development of the supply chain by reversing the stimulating effect of R&D capabilities, resulting in the production of safer, more environmentally friendly, and more cost-effective products that fully satisfy consumers' needs.


In the future, YOOZ will continue to prioritize consumer satisfaction and aim for long-term growth. They will spare no effort in ensuring compliance, safety, scientific research, innovation, and environmental friendliness, serving as a model for industry leaders. They will actively recruit talent and use their technological capabilities to push forward the development of the electronic cigarette industry, bringing more value to the industry's progress.


This article contains excerpts or reprints of third-party information, and the copyright belongs to the original media and author. If there is any infringement, please contact us for deletion. Any unit or individual that needs to reprint, please contact the author and do not repost directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24